Ultra-Low Dose of Rituximab Safely Eases Rheumatoid Arthritis Over Long Term: Study

• Amy Norton HealthDay Reporter
• November 9, 2021
• Full Page

"Ultra-low" doses of the drug rituximab may be enough to keep some patients' rheumatoid arthritis under control for several years, a new, preliminary study suggests.

Researchers found that among 118 patients, low doses of the drug were comparable to standard ones in cont...